HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis.

Abstract
The efficacy of the combination of systemic enrofloxacin (5mg/kg twice with a 24-h interval, first dose i.v., second dose s.c.) and the nonsteroidal antiinflammatory agent ketoprofen (3mg/kg i.m. or 4 mg/kg per os daily for 1 to 3 d) treatment was compared with antiinflammatory treatment only in dairy cows with naturally occurring acute clinical Escherichia coli mastitis. A total of 132 cows with acute clinical mastitis and with confirmed growth of E. coli in a pretreatment milk sample were randomly allocated to 1 of 2 treatment groups. Response to treatment was evaluated clinically and by bacteriological culturing and determination of N-acetyl-beta-d-glucosaminidase (NAGase) activity on d 2 and 21 posttreatment. Enrofloxacin treatment did not increase bacteriological (90.5% of treated vs. 86.8% of nontreated cured) or clinical cure (46.7% of treated vs. 57.1% of nontreated cured), cow survival (95.3% of treated vs. 92.7% of nontreated), or quarter milk production assessed 21 d posttreatment (21.8 vs. 29.3% return to preinfection level for nontreated cows), nor did it decrease mammary gland tissue damage estimated using determination of milk NAGase activity (24.0+/-0.3 vs. 18.3+/-1.3 pmol of 4-methylumbelliferone per min per microL for nontreated cows). Treatment did not influence the number of study cows remaining in the herd after 6 mo (71.9% of treated vs. 80.6% of nontreated). The only significant effects of enrofloxacin were enhancing the bacteriological cure (odds ratio=3.32 for treated cows) and decreasing the clinical cure (odds ratio=0.05 for treated cows) on d 2 posttreatment. Our results did not support the use of enrofloxacin to treat acute clinical E. coli mastitis.
AuthorsL Suojala, H Simojoki, K Mustonen, L Kaartinen, S Pyörälä
JournalJournal of dairy science (J Dairy Sci) Vol. 93 Issue 5 Pg. 1960-9 (May 2010) ISSN: 1525-3198 [Electronic] United States
PMID20412909 (Publication Type: Journal Article)
CopyrightCopyright 2010 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Infective Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Fluoroquinolones
  • Enrofloxacin
  • Ketoprofen
  • Acetylglucosaminidase
Topics
  • Acetylglucosaminidase (metabolism)
  • Animals
  • Anti-Infective Agents (therapeutic use)
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Cattle
  • Enrofloxacin
  • Escherichia coli Infections (drug therapy, veterinary)
  • Female
  • Fluoroquinolones (pharmacology, therapeutic use)
  • Ketoprofen (pharmacology, therapeutic use)
  • Lactation (drug effects)
  • Mastitis, Bovine (drug therapy)
  • Milk (enzymology, metabolism, microbiology)
  • Random Allocation
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: